Published in Lancet on November 07, 1998
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev (2009) 4.22
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ (2008) 2.02
Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Serv Res (2009) 1.71
Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients. Eur J Clin Pharmacol (2007) 1.50
"Smart Forms" in an Electronic Medical Record: documentation-based clinical decision support to improve disease management. J Am Med Inform Assoc (2008) 1.47
Recommendations for patients undertaking self management of oral anticoagulation. BMJ (2001) 1.47
Pathology tests: is the time for demand management ripe at last? J Clin Pathol (2003) 1.39
Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation. J Med Genet (2006) 1.38
Computerized clinical decision support systems for acute care management: a decision-maker-researcher partnership systematic review of effects on process of care and patient outcomes. Implement Sci (2011) 1.33
Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review. Implement Sci (2011) 1.14
Effect of an interactive voice response system on oral anticoagulant management. CMAJ (2009) 1.08
A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation. J Clin Pathol (2003) 1.07
Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records. BMC Clin Pharmacol (2004) 0.99
Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis. BMC Health Serv Res (2004) 0.83
Best practice in primary care pathology: review 8. J Clin Pathol (2006) 0.83
Effects of computer-assisted oral anticoagulant therapy. Thromb J (2012) 0.80
Thromboembolism. BMJ Clin Evid (2011) 0.79
A multi-factorial analysis of response to warfarin in a UK prospective cohort. Genome Med (2016) 0.78
Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic. Eur J Clin Pharmacol (2011) 0.78
Improving anticoagulation therapy using point-of-care testing and a standardized protocol. Ann Fam Med (2008) 0.78
Anticoagulation in patients with thromboembolic disease. Thorax (2001) 0.75
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost (2000) 2.74
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin Nutr (1994) 2.12
[Venous thromboembolism--incidence and risk factors in Oslo]. Tidsskr Nor Laegeforen (1998) 2.03
The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost (2013) 1.92
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation (1996) 1.80
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations. Am J Hum Genet (2001) 1.70
32P-incorporation PCR for the detection of rearrangements at the TCR-gamma locus. Diagn Mol Pathol (1996) 1.52
A comparison of artificially-depleted, lyophilized coumarin and fresh coumarin plasmas in thromboplastin calibration. European Concerted Action on Anticoagulation. Br J Haematol (1998) 1.44
[Prevalence of asthma in the city of Porto]. Acta Med Port (1994) 1.42
A simplified statistical method for local INR using linear regression. European Concerted Action on Anticoagulation. Br J Haematol (1997) 1.40
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol (1991) 1.39
The importance of technology for achieving superior outcomes from intensive care. Brazil APACHE III Study Group. Intensive Care Med (1996) 1.38
Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol (2007) 1.25
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Danish National In-Vitro Fertilization Registry 1994 and 1995: a controlled study of births, malformations and cytogenetic findings. Hum Reprod (1999) 1.22
Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently. Am J Clin Nutr (1999) 1.18
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb (1993) 1.14
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal. J Thromb Haemost (2013) 1.12
Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun (2000) 1.12
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal. J Thromb Haemost (2013) 1.10
Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int J Biochem Cell Biol (2009) 1.08
Arenosclerins A-C and haliclonacyclamine E, new tetracyclic alkaloids from a Brazilian endemic Haplosclerid sponge Arenosclera brasiliensis. J Nat Prod (2000) 1.07
Genetic influence on thrombotic risk markers in the elderly--a Danish twin study. J Thromb Haemost (2005) 1.02
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
Survival predictors in advanced non-small cell lung cancer. Lung Cancer (1995) 0.97
Histology of neuroblastoma involving bone marrow. Br J Haematol (1989) 0.97
Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. J Am Coll Cardiol (1998) 0.96
European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins. Steering Committee. Thromb Haemost (1996) 0.96
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res (1996) 0.96
Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on Anticoagulation. Am J Clin Pathol (1998) 0.95
Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study. J Clin Pathol (1984) 0.95
Massive right atrial thrombus associated with a Chiari network and a Hickman catheter. Am J Clin Pathol (1987) 0.94
The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies. J Thromb Haemost (2011) 0.94
Hepatosplenic schistosomiasis mansoni: ultrasound manifestations. Radiology (1984) 0.94
Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost (2000) 0.94
Morbidity associated with Schistosoma mansoni infection determined by ultrasound in an endemic area of Brazil, Caatinga do Moura. Am J Trop Med Hyg (2001) 0.94
European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol (2002) 0.93
Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis (1990) 0.92
The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol (2000) 0.92
European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors. J Clin Pathol (2003) 0.92
The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis (1992) 0.92
Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr (1994) 0.92
Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost (1999) 0.91
FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil. Genes Immun (2011) 0.91
Fibrinolytic activity and arterial disease. Lancet (1994) 0.90
European Concerted Action on Anticoagulation--comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors. Thromb Haemost (2002) 0.90
The effect of sample size on fresh plasma thromboplastin ISI determination. Br J Haematol (1999) 0.90
Treatment of donor sites. A controlled trial with fucidin gauze. Scand J Plast Reconstr Surg (1972) 0.90
The investigation and management of inherited thrombophilia. Clin Lab Haematol (1999) 0.89
Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost (2003) 0.89
Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction. Heart (2000) 0.89
Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr (1994) 0.88
Chlamydia pneumoniae and COPD exacerbation. Thorax (2002) 0.88
Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Intern Med (1991) 0.88
Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis. Br J Urol (1997) 0.88
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. Hum Reprod (2002) 0.87
Change in social status and risk of low birth weight in Denmark: population based cohort study. BMJ (1997) 0.86
Selenocysteine incorporation in Kinetoplastid: selenophosphate synthetase (SELD) from Leishmania major and Trypanosoma brucei. Mol Biochem Parasitol (2008) 0.86
Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study. J Thromb Haemost (2003) 0.86
Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems. Thromb Res (2000) 0.86
Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers. Heart (2003) 0.86
A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis (1983) 0.85
Sedation with midazolam in flexible bronchoscopy: a prospective study. Rev Port Pneumol (2012) 0.85
Detection of mutations in ectopic factor VIII transcripts from nine haemophilia A patients and the correlation with phenotype. Hum Genet (1995) 0.84
Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT. Cell Oncol (2005) 0.84
Abdominal ultrasonography in hepatolenticular degeneration. A study of 33 patients. Arq Neuropsiquiatr (1987) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet (1995) 0.83
Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study. J Intern Med (2000) 0.83
Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb (1993) 0.83
The importance of "like to like" ISI calibrations with freeze dried plasmas. European Concerted Action on Anticoagulation. J Clin Pathol (1998) 0.82
Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol (1997) 0.82
Detection and accurate sizing of PCR product by automated scanning: improved detection of immunoglobulin gene rearrangements in ALL. Br J Haematol (1993) 0.82
Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up. J Cardiovasc Risk (1995) 0.82
Danish National IVF Registry 1994 and 1995. Treatment, pregnancy outcome and complications during pregnancy. Acta Obstet Gynecol Scand (2000) 0.82
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest (2007) 0.81
Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol (1997) 0.81
The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thromb Haemost (1998) 0.81
The European Concerted Action on Anticoagulation (ECAA) evaluation of a set of lyophilized normal plasmas to establish the normal prothrombin time for coagulometer systems. Thromb Haemost (1998) 0.81
Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study. BJOG (2003) 0.81
Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb Res (2009) 0.81
Purification and partial characterization of an L-amino acid oxidase from bushmaster snake (Surucucu Pico de Jaca) Lachesis muta muta venom. Braz J Med Biol Res (1991) 0.81
Ultrasonographic evaluation of ascaris in the biliary tract. Radiology (1983) 0.81
The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition. Thromb Res (1986) 0.81
Antithrombin-III and platelets in haemodialysis patients. Nephron (1981) 0.81
The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate. J Thromb Haemost (2013) 0.80
Role of interventional radiology in the management of morbidly adherent placenta. J Obstet Gynaecol (2010) 0.80
p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer. Virchows Arch (2000) 0.80
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit? Thromb Haemost (1999) 0.80
N-acetyl-gamma-hydroxyvaline lactone, an unusual amino acid derivative from a marine streptomycete. J Nat Prod (2000) 0.80
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. J Intern Med (1990) 0.80
A novel splice donor mutation affecting position +3 in intron 6 of the factor VIII gene. Hum Mol Genet (1994) 0.80
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest (1995) 0.80
[Migraine with aura (classical migraine) in patients examined for cerebrovascular disease]. Ugeskr Laeger (1990) 0.80
Cytomegalovirus retinitis in an immunocompromised infant: a case report and review of the literature. Case Rep Ophthalmol (2011) 0.80
Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscler Thromb Vasc Biol (1997) 0.80